Immunogenic cell death in a combined synergic gene- and immune-therapy against cancer

It was previously demonstrated that engineered mesenchymal stem cells (MSCs) which express a high level of a very efficient modified gene CYP2B6* (CYP2B6TM-RED) acting as a suicide gene (MSC-2B6*) in combination with cyclophosphamide (CPA) constitute a powerful cell/gene therapy approach for solid t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayagom, Benjamin, Amara, Ikrame, Habiballah, Meryem, Amrouche, Floriane, Beaune, Philippe, de Waziers, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844315/
https://www.ncbi.nlm.nih.gov/pubmed/31741770
http://dx.doi.org/10.1080/2162402X.2019.1667743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844315/
https://www.ncbi.nlm.nih.gov/pubmed/31741770
http://dx.doi.org/10.1080/2162402X.2019.1667743

Ejemplares similares